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a b s t r a c t
Background: Continuing chronic and sporadic high-level of lead exposure in some regions in the U.S. has
directed public attention to the effects of lead on human health. Long-term lead exposure has been
associated with faster cognitive decline in older individuals; however, genetic susceptibility to lead-
related cognitive decline during aging has been poorly studied.
Methods: We determined the interaction of APOE-epsilon variants and environmental lead exposure in
relation to age-related cognitive decline. We measured tibia bone lead by K-shell-x-ray fluorescence,
APOE-epsilon variants by multiplex PCR and global cognitive z-scores in 489 men from the VA-Normative
Aging Study. To determine global cognitive z-scores we incorporated multiple cognitive assessments,
including word list memory task, digit span backwards, verbal fluency test, sum of drawings, and pattern
comparison task, which were assessed at multiple visits. We used linear mixed-effect models with
random intercepts for individual and for cognitive test.
Results: An interquartile range (IQR:14.23 μg/g) increase in tibia lead concentration was associated with
a 0.06 (95% confidence interval [95%CI]: 0.11 to 0.01) lower global cognition z-score. In the presence
of both ε4 alleles, one IQR increase in tibia lead was associated with 0.57 (95%CI: 0.97 to 0.16;
p-value for interaction: 0.03) lower total cognition z-score. A borderline association was observed in
presence of one ε4 allele (Estimate-effect per 1-IQR increase: 0.11, 95%CI: 0.22, 0.01) as well as lack of
association in individuals without APOE ε4 allele.
Conclusions: Our findings suggest that individuals carrying both ε4 alleles are more susceptible to lead
impact on global cognitive decline during aging.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
By 2020 as many as 42 million individuals worldwide will
suffer from dementia, and that number is expected to double by
2040 (Rizzi et al., 2014). Although lead exposure has reduced in
the last decades, a very recent state of emergency has been
declared in Flint, Michigan, U.S. because of high-levels of lead in
drinking water, which has highlighted the importance of lead
exposure in public health (Wang, 2015). Lead has been repeatedly
associated with adverse cognitive effects both in children and
older individuals (Koller et al., 2004; Wright et al., 2003), due to
occupational (ATSDR, 2007) and environmental exposures
(Weisskopf et al., 2007). However, very few susceptibility bio-
markers are available to predict the impact of environmental
toxicants, including lead exposure, on age-related cognitive de-
cline. Availability of such biomarkers is critical to design targeted
preventive strategies on those at risk, and to reduce the burden of
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cognitive impairment during aging. Apolipoprotein E (APOE) ep-
silon-4 allele (ε4), is one of the best known genetic risk markers
for cognitive function impairment and Alzheimer's disease (Liu
et al., 2013). Few studies have evaluated the role of genetic sus-
ceptibility in the cognitive effects of environmental lead exposures
(Wang et al., 2007), and while a prior study addressed occupa-
tional lead exposure (Stewart et al., 2002), no previous environ-
mental study has evaluated the role of the APOE ε4 allele. In this
study, we evaluated whether the APOE epsilon alleles modified the
association between tibia bone lead and global cognitive function
in a cohort of male participants aged 41–77 years (mean: 58.58,
SD: 6.52 yrs) at baseline in the Veterans Affairs (VA) - Normative
Aging Study (NAS).
2. Material and methods
2.1. Participants
The present analysis was conducted on 489 elderly men from
the VA – NAS (Bell et al., 1966). NAS was approved by the In-
stitutional Review Boards (IRB) at participating institutions and
participants have provided written informed consent at each visit.
2.2. Bone lead measurements and APOE ε4 genotyping
We focused our analysis in tibia lead (cortical bone) as its half-
life estimates may reach up to 20 years (Hu et al., 1998). Tibia lead
measurements were performed on average 1.6 times per partici-
pant (SD: 0.74, min¼1, max¼4) at the mid-tibial shaft by K-shell
x-ray fluorescence with an ABIOMED KXRF, and we used the clo-
sest measurement to cognitive evaluation for analysis. APOE ep-
silon variants were determined as previously described (Prada
et al., 2014).
2.3. Neuropsychological testing
For cognitive performance, we evaluated “total” cognitive
function integrating multiple cognitive tests (Table 1) (Power et al.,
2014; 2013). Cognitive data were collected at multiple visits ap-
proximately 3.6 years apart, with nearly 2.7 visits (min¼1,
max¼7) per subject and 3566 visits in total were included, from
1993 to 2004.
2.4. Data analysis
We assessed the association between tibia lead and “total”
cognitive function by incorporating the multiple cognitive as-
sessments at multiple visits, and treating each cognitive score as a
repeat measure of underlying overall cognition. We used linear
mixed-effect models with random intercepts for individual and for
cognitive test, determining association with global cognitive de-
cline. Also, to determine the effect of lead on overall cognition as
well as the interaction of APOE epsilon variants, we explored the
association using only the first cognitive assessment. To determine
effect modification by APOE epsilon variants in the association of
tibia lead with overall cognitive change, we added multiplicative
interaction terms. We adjusted for age at cognitive assessments,
education 6-11, 12-16,416 years of education), first language
(English, not English), computer experience (yes, no), smoking
status (never, current, former), physical activity (o12, 12–30, and
430 metabolic equivalent hours) (Jetté et al., 1990), alcohol intake
(o2 or Z2 drinks/day), diabetes (self-reported or having fasting
glucose above 126 mg/dl) and census tract percentages of the
participants that are non-white and with at least a college degree.
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significant. We used SAS software (Version 9.3, SAS Institute Inc.,
Cary, NC) for all statistical analyses.
3. Results
Most of the men were former smokers (55.8%), reported be-
tween 12 and 16 years of education (51.9%), exhibited overweight
or obesity (79.7%), and were Caucasian (95%). Additional char-
acteristics at baseline by subgroups and bone levels are shown in
Table 2. Lower levels of lead were observed in younger, more
educated men and in those who had computer experience (Ta-
ble 2). At least one ε4 allele was observed in 23.0% of men and the
ε4ε4 haplotype was observed in 2.7% (Table 3), concordant with
frequencies observed worldwide (Komurcu-Bayrak et al., 2011).
Haplotype ε1ε2 was observed in only 2 individuals and included
in the ‘None’ ε4 allele group for analysis. No differences in tibia
lead levels were observed among APOE haplotypes (p¼0.27 for
analysis of variance of tibia lead levels between allelic groups;
p¼0.09 for haplotypes).
We did not observe association between APOE haplotype or
APOE ε4 allele status on cognitive change (Supp. Table 1). How-
ever, in analysis including all individuals, an increase of one in-
terquartile range (IQR: 14.23 μg/g) in tibia lead concentration was
associated with a 0.06 (95% confidence interval (95%CI): 0.11 to
0.01) lower point total cognition z-score (Table 4). Additive
models of APOE ε4 allele status showed that in carriers of both
APOE ε4 alleles, one IQR increase in tibia lead was associated with
0.57 (95%CI: 0.97 to 0.16) lower point total cognition z-score.
In the presence of only one APOE ε4 allele, a borderline association
was observed (Estimate effect per 1-IQR increase: 0.11, 95%CI:
0.22, 0.01). When APOE ε4 allele was absent, there was little
evidence of an association between lead and cognition (Estimate
effect per 1-IQR increase: 0.04, 95%CI: 0.09 to 0.02) (Table 4).
In analyses considering APOE haplotypes, ε4ε4 carriers had a 0.57
lower points total cognition z-score (95%CI: 0.97 to 0.16) for
each IQR increase in tibia lead. Also, ε4ε4 showed an interaction in
the association between tibia lead and total cognition z-score (p-
value for interaction¼0.010) (Table 4). A borderline effect was
observed in those individuals carrying one APOE ε4 allele (Esti-
mate effect per 1-IQR increase in tibia lead for ε3ε4:0.10, 95%CI
0.21 to 0.02; for ε4ε1:0.43, 95%CI: 0.91, 0.05). We did not
observe association among those individuals lacking APOE ε4 al-
lele (Estimate per 1-IQR increase for ε3ε3: 0.03, 95%CI: 0.09 to
0.03; Estimate per 1-IQR increase for ε2ε3: 0.06, 95%CI: 0.18 to
0.06) with a likelihood ratio test (LRT) for the interaction of
Table 2
Demographic characteristics of VA-Normative Aging Study men at the initial ex-
amination of cognitive function (N¼489).
Variable n % Tibia lead (μg/g)
Median IQR
Age, years
o 60 285 58.3% 17 (5–29)
60–69 176 36.0% 21 (6–36)
470 28 5.7% 26 (6–45)
Education
6–11 yrs 143 29.3% 23 (8–38)
12–16 yrs 254 51.9% 18 (6–30)
4 16 yrs 92 18.8% 14 (3–25)
Smoking status
Never 158 32.3% 18 (2–34)
Former 273 55.8% 20.5 (4–36)
Current 58 11.9% 19 (7–31)
Alcohol consumption
Yes 95 19.4% 19 (6–32)
No 394 80.6% 19 (4–34)
History of diabetesa
Yes 34 6.9% 21.5 (5–37)
No 455 93.1% 19 (5–33)
Computer experience
Yes 275 56.2% 17 (4–30)
No 214 43.8% 20 (4–36)
English as first language
Yes 487 99.6% 19 (5–33)
Body mass index
r25 99 20.3% 18 (5–31)
425 390 79.7% 19 (4–34)
Physical activity (MET-hr)
o12 272 55.6% 19 (3–35)
12–30 131 26.8% 19 (8–30)
430 86 17.6% 18 (3–33)
MET-hr: metabolic equivalent hours.
a History of diabetes defined as reporting a diagnosis of diabetes or having
fasting glucose above 126 mg/dl. IQR¼ Interquartile range.
Table 3
APOE-epsilon ε4 allele and haplotypes frequencies, and tibia lead levels in the VA-
Normative Aging Study (N¼489).
Variable n % Tibia lead (μg/g)
Median IQR
ε4 Allele frequencies
None 364 74.3 19 (13–28)
One ε4 allele 112 23.0 20 (13–26)
Both ε4 alleles 13 2.7 13 (11–18)
Haplotype frequenciesa
ε3ε3 305 62.4 19 (5–33)
ε3ε4 105 21.5 20 (7–33)
ε2ε3 57 11.7 20 (6–34)
ε4ε4 13 2.7 13 (6–20)
ε1ε4 7 1.4 14 (0–31)
a Haplotype ε1ε2 was observed in only 2 individuals, and included in the ‘None’
ε4 allele group for analysis. Haplotypes ε1ε1, and ε2ε4 were not observed. VA:
Veterans Affairs – Normative Aging Study.
Table 4
Difference in global cognitive z-score per an interquartile range (14.23 μg/g) in-







All individuals 0.058 (0.107, 0.011) 0.018
By APOE allele
None 0.036 (0.090, 0.019) 0.197 .
One ε4 allele 0.105 (0.216, 0.007) 0.066 0.336




ε3ε3 0.032 (0.094, 0.030) 0.308 .
ε3ε4 0.098 (0.213, 0.017) 0.094 0.462
ε2ε3 0.062 (0.183, 0.059) 0.313 0.865
ε4ε4 0.565 (0.973, 0.157) 0.007 0.010
ε1ε4 0.431 (0.911, 0.049) 0.081 0.250
LRTb 0.093
Adjusted for age, education, computer experience, physical activity, census tract
percentage of the participants that is are non-white, census tract percentage of the
participants with a college degree, and diabetes mellitus. LRT¼Likelihood ratio test.
a LRT for the interaction of allele.
b LRT for the interaction of haplotypes. VA: Veterans Affairs – Normative Aging
Study.
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haplotypes¼0.09 (Table 4).
Cross-sectional analysis —using only the first cognitive as-
sessment— to determine the impact on global cognition, showed a
lack of effect of lead on cognitive performance (Estimate effect per
1-IQR increase¼0.004, 95%CI 0.058 to 0.067). A borderline effect
on carriers of both APOE ε4 alleles was observed (Estimate effect
per 1-IQR increase¼1.14, 95%CI 2.29 to 0.01). No association
was found in the presence of only one or in absence of APOE ε4
allele (Supp. Table 2). We also tested the role of age in the inter-
action observed for APOE ε4 allele, but no significant association
was observed (Supp. Table 3).
4. Discussion
In this cohort of aging men, we found that the association of
bone lead with age-related cognitive decline was stronger in APOE
ε4 allele carriers, with the strongest statistically significant asso-
ciation in those with two copies of the allele. To the best of our
knowledge, this is the first report of a potential interaction of APOE
ε4 allele with environmental lead exposure in relation to cognitive
decline in elderly individuals.
Several studies have associated cognitive impairment with low-
level lead exposure (Weisskopf et al., 2004). One previous cross-
sectional analysis in former organolead workers found interaction
(po0.05) of APOE ε4 in three out of 20 cognitive tests (Stewart
et al., 2002). This study was also cross sectional and the interaction
between APOE ε4 and lead for cognitive decline was not assessed.
The mechanisms linking lead and cognitive function are unknown;
however, neural dysfunction has been attributed to lead's ability to
substitute for calcium, which plays a central role in synapsis, mi-
tochondria function, among other cellular processes (White et al.,
2007). APOE ε4 genetic variants have been repeatedly associated
with impaired cognition in the elderly and individuals with APOE
genetic susceptibility show more pronounced age-related reduc-
tion in hippocampal volume (Lind et al., 2006), decreased anti-
oxidant capacity (Miyata and Smith, 1996), and altered use of
nutrients (Reiman et al., 2004). All those characteristics may make
APOE ε4 carriers more susceptible to lead-induced neuroin-
flammation. Previous studies have found that other genetic sus-
ceptibilities may also modify the rate of lead-related cognitive
decline (Wilker et al., 2011). In our study, we also found the pre-
sence of haplotypes showing the ε1 allele (haplotypes ε1ε2 and
ε1ε4). Scientific literature is full of data claiming that APOE ε1
allele is a very rare allele, even to the point of considering it almost
as ‘inexistent’ in the clinical practice. However, this comment is
related to the ε1ε1 condition, which was not observed in our
population (Steinmetz et al., 1990). We did not find haplotype
ε2ε4, which has also been reported in very low frequencies in
similar epidemiological studies (Koopal et al., 2016).
Our study has several limitations: the study participants are
male Caucasians and our results may not apply to other ethnic
groups, e.g. APOE ε4 have showed an attenuated effect in Hispanics
(Farrer et al., 1997). Also, although most evidence suggests APOE
ε4 effect is stronger in women, (Ungar et al., 2014) the APOE-
gender interaction remains controversial (Qiu et al., 2004). Also,
non-differential misclassification of cognitive status is likely, but
reduced by our use of all available cognitive data as a measure of
age-related cognitive decline. Also, the number of individuals with
APOE ε4ε4 haplotype is small (N¼13), and it could bias our finding
and give rise to the possibility of type-1 error. However, very few
cohorts worldwide have determined concomitantly bone lead,
APOE genotype, and have assessed cognitive function long-
itudinally during aging, and including several variables involved in
cognitive performance during aging.
5. Conclusions
In summary, elderly men with two copies of the APOE ε4 allele
showed greater cognitive decline associated with lead exposure.
Based on the long retention of lead in the body, the rapid growth
of older populations in modern societies and the special suscept-
ibility to chronic low-levels of lead exposure in some minorities
and socioeconomically disadvantaged groups, our findings stress
the need to control lead to protect cognitive function in the
elderly.
Conflict of interest
The authors have no conflict of interest to disclose.
Funding
This study was funded by the National Institute of Environ-
mental Health Sciences (NIEHS) (R01ES021733 and R01ES015172).
The US Department of Veterans Affairs (VA) Normative Aging
Study (NAS) is supported by the VA Cooperative Studies Program/
ERIC, Massachusetts Veterans Epidemiology Research and In-
formation Center (MAVERIC). Additional support to the VA-NAS
was provided by the US Department of Agriculture, Agricultural
Research Service (contract 53-K06-510). DP is financially sup-
ported by CONACYT-México, and the Fundación México en Har-
vard. AS3 is supported by a VA Clinical Sciences Research and
Development Senior Research Career Scientist award. Funding
sources had no involvement in study design, collection, analysis
and interpretation of data; in the writing of the manuscript; and in
the decision to submit the article for publication.
Appendix A. Supplementary material
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.envres.2016.07.
034.
References
ATSDR, U.S., 2007. Toxicological Profile for Lead. US Department of Health and
Human Services,.
Bell, B., Rose, C.L., Damon, A., 1966. The Veterans administration longitudinal study
of healthy aging. Gerontologist 6, 179–184.
Farrer, L.A., Cupples, L.A., Haines, J.L., Hyman, B., Kukull, W.A., Mayeux, R., Myers, R.
H., Pericak-Vance, M.A., Risch, N., van Duijn, C.M., 1997. Effects of age, sex, and
ethnicity on the association between apolipoprotein E genotype and Alzheimer
disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Con-
sortium. JAMA 278, 1349–1356.
Fillenbaum, G.G., van Belle, G., Morris, J.C., Mohs, R.C., 2008. Consortium to Estab-
lish a Registry for Alzheimer’s Disease (CERAD): the first twenty years. Alz-
heimer. Dement. : J. Alzheimer. Assoc. 4, 96–109.
Hu, H., Rabinowitz, M., Smith, D., 1998. Bone lead as a biological marker in epi-
demiologic studies of chronic toxicity: conceptual paradigms. Environ. Health
Perspect. 106, 1–8.
Jetté, M., Sidney, K., Blümchen, G., 1990. Metabolic equivalents (METS) in exercise
testing, exercise prescription, and evaluation of functional capacity. Clin. Car-
diol. 13, 555–565.
Koller, K., Brown, T., Spurgeon, A., Levy, L., 2004. Recent developments in low-level
lead exposure and intellectual impairment in children. Environ. Health Per-
spect. 112, 987–994.
Komurcu-Bayrak, E., Onat, A., Yuzbasiogullari, B., Mononen, N., Laaksonen, R.,
Kähönen, M., Hergenc, G., Lehtimäki, T., Erginel-Unaltuna, N., 2011. The APOE
219G/T and þ113G/C polymorphisms affect insulin resistance among Turks.
Metab. Clin. Exp. 60, 655–663. http://dx.doi.org/10.1016/j.metabol.2010.06.016.
Koopal, C., Geerlings, M.I., Muller, M., de Borst, G.J., Algra, A., van der Graaf, Y.,
Visseren, F.L.J., SMART Study Group, 2016. The relation between apolipoprotein
E (APOE) genotype and peripheral artery disease in patients at high risk for
D. Prada et al. / Environmental Research 151 (2016) 101–105104
cardiovascular disease. Atherosclerosis 246, 187–192. http://dx.doi.org/10.1016/
j.atherosclerosis.2016.01.009.
Letz, R., 1991. NES2 User’s Manual (Version 4.4). Winchester, MA.
Lind, J., Persson, J., Ingvar, M., Larsson, A., Cruts, M., Van Broeckhoven, C., Adolfsson,
R., Bäckman, L., Nilsson, L.-G., Petersson, K.M., Nyberg, L., 2006. Reduced
functional brain activity response in cognitively intact apolipoprotein E epsi-
lon4 carriers. Brain 129, 1240–1248. http://dx.doi.org/10.1093/brain/awl054.
Liu, C.-C., Liu, C.-C., Kanekiyo, T., Xu, H., Bu, G., 2013. Apolipoprotein E and Alz-
heimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106–118.
http://dx.doi.org/10.1038/nrneurol.2012.263.
Miyata, M., Smith, J.D., 1996. Apolipoprotein E allele-specific antioxidant activity
and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat.
Genet. 14, 55–61. http://dx.doi.org/10.1038/ng0996-55.
Power, M.C., Korrick, S., Tchetgen, E.J., Nie, L.H., Grodstein, F., Hu, H., Weuve, J.,
Schwartz, J., Weisskopf, M.G., 2014. Lead exposure and rate of change in cog-
nitive function in older women. Environ. Res 129, 69–75. http://dx.doi.org/
10.1016/j.envres.2013.12.010.
Power, M.C., Weisskopf, M.G., Alexeeff, S.E., Wright, R.O., Coull, B.A., Spiro III, A.,
Schwartz, J., 2013. Modification by hemochromatosis gene polymorphisms of
the association between traffic-related air pollution and cognition in older
men: a cohort study. Environ. Health 12. http://dx.doi.org/10.1186/
1476-069X-12-16.
Prada, D., Colicino, E., Power, M.C., Cox, D.G., Weisskopf, M.G., Hou, L., Spiro III, A.,
Vokonas, P., Zhong, J., Sanchez-Guerra, M., Herrera, L.A., Schwartz, J., Baccarelli,
A.A., 2014. Influence of multiple APOE genetic variants on cognitive function in
a cohort of older men - results from the Normative Aging Study. BMC Psy-
chiatry 14, 223. http://dx.doi.org/10.1186/s12888-014-0223-x.
Qiu, C., Kivipelto, M., Agüero-Torres, H., Winblad, B., Fratiglioni, L., 2004. Risk and
protective effects of the APOE gene towards Alzheimer’s disease in the Kung-
sholmen project: variation by age and sex. J. Neurol. Neurosurg. Psychiatr. 75,
828–833.
Reiman, E.M., Chen, K., Alexander, G.E., Caselli, R.J., Bandy, D., Osborne, D., Saunders,
A.M., Hardy, J., 2004. Functional brain abnormalities in young adults at genetic
risk for late-onset Alzheimer’s dementia. Proc. Natl. Acad. Sci. USA 101,
284–289. http://dx.doi.org/10.1073/pnas.2635903100.
Rizzi, L., Rosset, I., Roriz-Cruz, M., 2014. Global epidemiology of dementia: Alzhei-
mer’s and vascular types. Biomed. Res. Int. 2014, 908915. http://dx.doi.org/
10.1155/2014/908915.
Steinmetz, A., Assefbarkhi, N., Eltze, C., Ehlenz, K., Funke, H., Pies, A., Assmann, G.,
Kaffarnik, H., 1990. Normolipemic dysbetalipoproteinemia and hyperlipopro-
teinemia type III in subjects homozygous for a rare genetic apolipoprotein E
variant (apoE1). J. Lipid Res. 31, 1005–1013.
Stewart, W.F., Schwartz, B.S., Simon, D., Kelsey, K., Todd, A.C., 2002. ApoE genotype,
past adult lead exposure, and neurobehavioral function. Environ. Health Per-
spect. 110, 501–505.
Ungar, L., Altmann, A., Greicius, M.D., 2014. Apolipoprotein E, gender, and Alzhei-
mer’s disease: an overlooked, but potent and promising interaction. Brain
Imaging Behav. 8, 262–273. http://dx.doi.org/10.1007/s11682-013-9272-x.
Wang, F.T., Hu, H., Schwartz, J., Weuve, J., Spiro, A.S., Sparrow, D., Nie, H., Silverman,
E.K., Weiss, S.T., Wright, R.O., 2007. Modifying Effects of the HFE polymorph-
isms on the association between lead burden and cognitive decline. Environ.
Health Perspect. 115, 1210–1215. http://dx.doi.org/10.1289/ehp.9855.
Wang, Y., 2015. In Flint, Mich., there's so much lead in children's blood that a state
of emergency is declared. Wash. Post.
Wechsler, D., 1981. The psychometric tradition: developing the Wechsler adult
intelligence scale. Contemp. Educ. Psychol.
Weisskopf, M.G., Proctor, S.P., Wright, R.O., Schwartz, J., Spiro, A., Sparrow, D., Nie,
H., Hu, H., 2007. Cumulative lead exposure and cognitive performance among
elderly men. Epidemiology 18, 59–66. http://dx.doi.org/10.1097/01.
ede.0000248237.35363.29.
Weisskopf, M.G., Wright, R.O., Schwartz, J., Spiro, A., Sparrow, D., Aro, A., Hu, H.,
2004. Cumulative lead exposure and prospective change in cognition among
Elderly men: the VA normative aging study. Am. J. Epidemiol. 160, 1184–1193.
http://dx.doi.org/10.1093/aje/kwh333.
White, L.D., Cory-Slechta, D.A., Gilbert, M.E., Tiffany-Castiglioni, E., Zawia, N.H.,
Virgolini, M., Rossi-George, A., Lasley, S.M., Qian, Y.C., Basha, M.R., 2007. New
and evolving concepts in the neurotoxicology of lead. Toxicol. Appl Pharm. 225,
1–27. http://dx.doi.org/10.1016/j.taap.2007.08.001.
Wilker, E., Korrick, S., Nie, L.H., Sparrow, D., Vokonas, P., Coull, B., Wright, R.O.,
Schwartz, J., Hu, H., 2011. Longitudinal changes in bone lead levels: the VA
Normative Aging Study. J. Occup. Environ. MEd. 53, 850–855. http://dx.doi.org/
10.1097/JOM.0b013e31822589a9.
Wright, R.O., Tsaih, S.W., Schwartz, J., Spiro III, A., McDonald, K., Weiss, S.T., Hu, H.,
2003. Lead exposure biomarkers and mini-mental status exam scores in older
men. Epidemiology 14, 713–718. http://dx.doi.org/10.1097/01.
EDE.0000081988.85964.db.
D. Prada et al. / Environmental Research 151 (2016) 101–105 105
